{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:25:30Z","timestamp":1761560730096},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":511,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:p>Aims<jats:italic>:<\/jats:italic>\u2003<\/jats:p><jats:p>Recent studies suggest that primary low\u2010grade gastric lymphomas of mucosa\u2010associated lymphoid tissue (MALT) are cured in many cases between 1 and 18\u2003months after <jats:italic>H. pylori<\/jats:italic> eradication. The aim of this study is to elucidate when complete regression (CR) of MALT lymphoma can be histologically predicted after <jats:italic>H. pylori<\/jats:italic> eradication.<\/jats:p><jats:p>Methods and results<jats:italic>:<\/jats:italic>\u2003<\/jats:p><jats:p>Twenty\u2010one patients with low\u2010grade gastric MALT lymphoma were treated with triple therapy (amoxicillin, clarythromycin and proton pump inhibitor) for 14\u2003days. Subsequently, they were followed up by sequential endoscopy and biopsy (number of biopsy specimens for each endoscopy is 3\u20138, with an average of 4) from 91 to 657\u2003days (average: 309\u2003\u00b1\u2003165\u2003days). Eradication of <jats:italic>H. pylori<\/jats:italic> infection was achieved in all patients. Nine patients were free of lymphoma at 1 to 2 months after eradication and remained in CR at 163\u2013657\u2003days. Twelve patients showed residual lymphoma at 1 to 2 months after eradication. Five out of 12 patients revealed only one or two small foci of lymphoma\u2010cell aggregation and showed a high incidence (80%) of CR at the latest biopsy (135\u2013434\u2003days, average 276\u2003\u00b1\u2003115\u2003days after eradication), while seven patients showed diffuse remains of lymphoma cells and indicated CR in only one case (14%) at 362\u2003days, partial regression in five cases at 130\u2013431\u2003days (average 227\u2003\u00b1\u2003114\u2003days), and no change in one case at 91\u2003days after eradication.<\/jats:p><jats:p>Conclusions<jats:italic>:<\/jats:italic>\u2003<\/jats:p><jats:p>These results suggest that CR of low\u2010grade MALT lymphoma can be predicted at 1 to 2 months after eradication therapy by checking histological changes of MALT lymphoma cells.<\/jats:p>","DOI":"10.1046\/j.1365-2559.2000.00927.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:09:26Z","timestamp":1047427766000},"page":"131-140","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["When can complete regression of low\u2010grade gastric lymphoma of mucosa\u2010associated lymphoid tissue be predicted after <i>Helicobacter pylori<\/i> eradication?"],"prefix":"10.1111","volume":"37","author":[{"given":"H","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Ajioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nishikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Maruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92035-Z"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92613-1"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90113-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-10-199505150-00006"},{"issue":"2","key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/annonc\/8.suppl_2.S37","article-title":"Helicobacter pylori eradication for the treatment of low\u2010grade gastric MALT lymphoma: Follow\u2010up together with sequential molecular studies","volume":"8","author":"Montalban C","year":"1997","journal-title":"Ann. Oncol."},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.4.1255.bloodjournal8741255"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.18.1350"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9322502"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt1997.37.4_265"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80014-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709050889"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059184"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1995.tb03403.x"},{"key":"e_1_2_6_17_2","first-page":"S1","article-title":"Guidelines for clinical trials in Helicobacter pylori infection","volume":"41","author":"Working Party of the European Helicobacter pylori Study Group.","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80003-0"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.1998.tb00537.x","article-title":"Helicobacter pylori consensus. Report on the 1997 Asian Pacific Consensus Conference on the management of Helicobacter pylori infection","volume":"13","author":"Lam SK","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"e_1_2_6_20_2","first-page":"199","article-title":"Guidelines of Helicobacter pylori eradication therapy","volume":"96","author":"Committee of Helicobacter pylori eradication therapy of the Japanese Society of Gastroenterology.","year":"1999","journal-title":"Jpn J. Gastroenterol."},{"key":"e_1_2_6_21_2","first-page":"909","article-title":"Malignant lymphoma of the stomach: collected eighty\u2010seven cases (in Japanese with English abstract)","volume":"15","author":"Watanabe H","year":"1980","journal-title":"Stomach Intestine"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90060-4"},{"key":"e_1_2_6_23_2","first-page":"15","article-title":"How to morphologically diagnose gastric marginal zone B\u2010cell lymphoma of MALT type (in Japanese with English abstract)","volume":"31","author":"Watanabe H","year":"1996","journal-title":"Stomach Intestine"},{"key":"e_1_2_6_24_2","first-page":"373","article-title":"The histological transition of malignant lymphoma of the stomach after H. pylori eradication","volume":"33","author":"Yamashita H","year":"1998","journal-title":"Stomach Intestine"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199605000-00005"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92823-5"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90314-3"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1021745"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810815)48:4<1053::AID-CNCR2820480433>3.0.CO;2-G"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70026-X"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.43.11.888"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1104"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1993.tb02049.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90071-4"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.6.837"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2559.2000.00927.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2559.2000.00927.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2559.2000.00927.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T13:31:28Z","timestamp":1698586288000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2559.2000.00927.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1046\/j.1365-2559.2000.00927.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2559.2000.00927.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}